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Abstract  
One of the goals for the development of more effective cancer therapies with reduced toxic side 
effects is the optimization of innovative treatments to selectively kill tumor cells. The use of 
nanovectors loaded with targeted therapeutic payloads is one of the most investigated strategies. In 
this paper superparamagnetic iron oxide nanoparticles (SPIONs) coated by a silica shell or 
uncoated, were functionalized with single-layer and bi-layer conjugated linoleic acid (CLA). Silica 
was used to protect the magnetic core from oxidation, improve the stability of SPIONs and tailor 
their surface reactivity. CLA was used as novel grafting biomolecule for its anti-tumor activity and 
to improve particle dispersibility. Mouse breast cancer 4T1 cells were treated with these different 
SPIONs. 
SPIONs functionalized with the highest quantity of CLA and coated with silica shell were the most 
dispersed. Cell viability was reduced by SPIONs functionalized with CLA in comparison with cells 
which were untreated or treated with SPIONs without CLA. As regards the types of SPIONs 
functionalized with CLA, the lowest viability was observed in cells treated with uncoated SPIONs 
with the highest quantity of CLA. 
In conclusion, the silica shell free SPIONs functionalized with the highest amount of CLA can be 
suggested as therapeutic carriers because they have the best dispersion and ability to decrease 4T1 
cell viability. 
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1. Introduction 
Some progress has been made in the field of anticancer therapies, although the research on new 
strategies to find even more effective therapies and to reduce their toxic side effects is still needed. 
The development of innovative treatments to kill tumor or metastatic cells is a challenging goal and 
for this reason, several possible approaches are under investigation. Today nanomedicine-based 
therapies are used in cancer research because they can bypass cancer cell multi-drug resistance, 
poor solubility of hydrophobic anti-cancer drugs, and the use of dangerous radiations [1]. Cancer 
nanomedicine pays particular attention to superparamagnetic iron oxide nanoparticles (SPIONs), 
that can reach the tumor sites carrying chemotherapeutic drugs, nucleic acids, monoclonal 
antibodies, viral vectors engineered with therapeutic suicide genes or shRNAs [1,2,3]. SPIONs are 
also used for diagnostic assays, generation of local hyperthermia for tumor therapy or tissue repair 
by delivering stem cells [4,5]. In fact, SPIONs can be combined with contrast fluorescent agents to 
improve cancer cell imaging [1]. In hyperthermia therapy, SPIONs are localized near the cancer site 
by magnetic driving and can induce localized heating by an external alternating magnetic field. For 
example in “in vitro” experiments, 14 nm magnetic nanoclusters killed about 74% of MCF-7 cancer 
cells, by applying temperature of 45°C for 1 hour [6]. Similarly, a temperature of 43°C for about 17 
minutes reduced the viability of HeLa cells exposed to an alternating magnetic field in the presence 
of silica coated iron oxide nanoparticles (NPs) [7]. SPIONs can be internalized in human 
mesenchymal stem cells without affecting viability and structure. Following this, the SPION-loaded 
stem cells can be attracted to specific sites by applying an external magnetic field [8]. 
When preparing SPIONs for the delivery of chemotherapeutic agents it is important to control their 
size, shape and surface properties, in order to assure their stability in solution and maintain 
superparamagnetic properties also in the presence of a variety of molecules. SPIONs which are 
smaller than 100 nm can easily circulate in the blood without being captured by reticulo-endothelial 
cells and can therefore selectively accumulate in the tumor microenvironment [3]. On the contrary 
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unmodified SPIONs tend to aggregate into large clusters and several studies suggest surface 
modification to avoid NP aggregation. A widely explored solution is surface coverage by polymers 
that has the unavoidable disadvantage of causing an increase in particle size and a potential loss in 
magnetic response [1]. Alternatively, small intermediary molecules can be used, acting as 
stabilizing agents and for the subsequent coupling of functional molecules.. Fatty acids, in particular 
oleic acid (OA), have been used as capping agent to obtain monodisperse SPIONs suspensions [9]. 
This study aimed to prepare functionalized SPIONs able to affect tumor cell viability. SPIONs, 
either coated with silica shell or uncoated, were prepared and functionalized with conjugated 
linoleic acid (CLA) in single- and bi-layer configuration. Silica was used for its ability to protect the 
magnetic core from oxidation, to improve the magnetite stability and to tailor the surface reactivity 
by improving biomolecule grafting [10]. CLA was chosen to improve SPION dispersion and to add 
an anticancer potential [11-13]. Fatty acids are crucial structural and functional cell components, 
and contribute to the functional/physical/chemical features of membranes [11-13]. Concerning 
cancer, it is well known that carcinogenesis is characterized by changes in fatty acid composition of 
membrane phospholipids. 
 
2. Materials and Methods 
2.1 Synthesis of superparamagnetic iron-oxide nanoparticles (Fe3O4) 
Among the different methods for the SPIONs production, the co-precipitation process was selected 
since it is simple, rapid and allows a high yield. An aqueous solution of Fe2+ and Fe3+ salts in a 1:2 
molar ratio was prepared by mixing FeCl2*4H2O and FeCl3*6H2O in bi-distilled water; 
subsequently the mixture was mechanically mixed at 300 rpm and Fe3O4 precipitation occurred by 
adding NH4OH drop by drop, until the pH of the mixture reached about 10. The suspension was put 
in ultrasound for 20 minutes; subsequently an aliquot was washed twice with bi-distilled water to 
remove the unreacted reagents (Fe3O4), while the other aliquot was not washed (Fe3O4-NW). 
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2.2 One-step synthesis of conjugated linoleic acid-capped Fe3O4 
In this procedure conjugated linoleic acid (CLA) was added in a single-step to the NP suspensions. 
A first synthesis of CLA-capped Fe3O4 NPs was carried out by adding drop by drop 3.0 µl of 
CLA/ml of NP suspension, to both washed (Fe3O4+CLA1) or not washed (Fe3O4-NW+CLA1),  NP 
under mechanical mixing. A second synthesis (Fe3O4+CLA2) was performed using a higher amount 
of CLA (4.5 µl CLA/ml of NPs suspension). All suspensions were heated at 80 °C with stirring at 
150 rpm for half hour. At the end of the functionalization process NP suspensions were washed 
twice with ethanol and re-suspended in bi-distilled water. 
 
2.3 Two-step synthesis of conjugated linoleic acid-capped Fe3O4 
In this procedure CLA was added in two steps to the NP suspensions. The two-step CLA-capped 
Fe3O4 NPs were synthesized by adding, in a second step, a further aliquot of CLA (3.0 µl CLA/ml 
of NP suspension) in the suspension of the one-step CLA-coated Fe3O4 NPs, both washed 
(Fe3O4+CLA1-TS) and not washed (Fe3O4-NW+CLA1-TS). The suspension was placed in orbital 
shaker at 80°C at 150 rpm for half hour. Subsequently, NPs were washed twice with ethanol and re-
suspended in bi-distilled water, adjusting the pH at 12 by adding NH4OH drop by drop [14]. 
 
2.4 Synthesis of silica-coated magnetite nanoparticles (Fe3O4-SiO2) 
In order to promote the single nanoparticles coating in a uniform way and obtain a stable 
suspension, Fe3O4 NPs were stabilized with 0.05 M citric acid. The pH was adjusted to 5.2 by 
dropwise NH4OH and the suspension was placed 90 minutes at room temperature in orbital shaker 
(KS 4000i control, IKA®) at 150 rpm allowing the deprotonation of two carboxylic groups of citric 
acid and the bond to the OH groups exposed by Fe3O4 NPs [15]. Subsequently, citric acid-
functionalized NPs were washed with bi-distilled water using an ultrafiltration device (Solvent 
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Resistant Stirred Cells - Merck Millipore) and re-suspended in bi-distilled water, adjusting the pH at 
about 10.1 to induce the deprotonation of the third carboxylic group, which allow an optimal NP 
dispersion. Then, magnetite NPs functionalized with citric acid were coated with a silica shell 
(Fe3O4-SiO2) by sol-gel method, by adding TEOS (tetraethoxysilane) as silica precursor, ethanol as 
catalyst and water as solvent, to Fe3O4 NPs suspended in a water and ethanol solution (water: 
ethanol 1:4) [16]. The pH of suspension was adjusted at 10 (NH4OH); the suspension was placed in 
orbital shaker at room temperature for 3 hours at 150 rpm. Subsequently, the Fe3O4-SiO2 NPs were 
washed with bi-distilled water using an ultrafiltration device (Solvent Resistant Stirred Cells - 
Merck Millipore) and re-dispersed in water. 
 
2.5 One-step synthesis of conjugated linoleic acid-capped Fe3O4-SiO2 
On the base of the results obtained for CLA coated Fe3O4, Fe3O4-SiO2 were functionalized with the 
higher CLA amount (4.5 µl CLA/ ml of NPs) with one-step procedure (Fe3O4-SiO2+CLA2). The 
suspension was heated at 80 °C and stirred at 150 rpm for half hour. At the end of the 
functionalization process CLA capped Fe3O4-SiO2 NPs were washed twice with ethanol and re-
suspended in bi-distilled water. 
Table 1 resumes the name and samples composition. All chemicals were purchased from Sigma-
Aldrich Co. (St Louis, MO, US). 
 
Table 1: name and composition of the samples 
Acronym NPs Washing CLA 
CLA [µl] per 1 ml of 
NPs suspension 
Fe3O4+CLA1 Fe3O4 Yes one-step 3.0 
Fe3O4-NW+CLA1 Fe3O4 No one-step 3.0 
Fe3O4+CLA1-TS Fe3O4 Yes two-step 3.0 
Fe3O4-NW+CLA1-TS Fe3O4 No two-step 3.0 
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Fe3O4+CLA2 Fe3O4 Yes one-step 4.5 
Fe3O4-SiO2+CLA2 Fe3O4-SiO2 Yes one-step 4.5 
 
2.6 Nanoparticles characterization 
All synthesized NPs were subjected to morphological characterization by scanning transmission 
electron microscopy (STEM, MERLIN Zeiss – Germany). For STEM observation, a drop of diluted 
NP suspension was deposited on a copper TEM grid with carbon film (SPI Supplies® Brand Lacey 
Carbon Coated 200 Mesh Copper Grids – JEOL S.p.A.). Fourier transformation infrared 
spectroscopy (FT-IR) was used to evidence the effective grafting of CLA and to confirm the 
presence of silica shell. FT-IR spectra were acquired in a Hyperion 2000 FT/IR (Tensor 27, Bruker 
Optics S.p.A, Ettlingen, Germany) from 4000 to 400 cm-1 and with 2 cm-1 resolution. OPUS 
software (v. 6.5, Bruker S.p.A) was used for instrumental control and spectral acquisition. 
Suspension stability and dispersion were evaluated in a semi-quantitative way by measuring the 
time required for particle precipitation. 
 
2.7 Cell Cultures: treatment of 4T1 with Fe3O4 NPs capped or not with CLA, or with CLA alone, 
and of MS1 cells with Fe3O4 NPs capped or not with CLA. 
Mouse breast cancer 4T1 cells were seeded (12,500 cells/cm2) in DMEM/F-12 medium 
supplemented with 2 mM glutamine, 1% (v/v) antibiotic/antimycotic solution, 10% (v/v) fetal 
bovine serum (FBS) and maintained at 37°C in a humidified atmosphere of 5% CO2 in air. Twenty-
four hours after seeding, culture medium was removed and replaced by the same medium not 
supplemented or supplemented with Fe3O4, Fe3O4-SiO2, Fe3O4+CLA1, Fe3O4-NW+CLA1, 
Fe3O4+CLA1-TS, Fe3O4-NW+CLA1-TS, Fe3O4+CLA2 and Fe3O4-SiO2+CLA2 at the 
concentrations 8 µg or 16 µg of NPs/100,000 cells. Twenty-four hours after seeding, the 4T1 cells 
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were also treated with CLA alone at 10 and 25 µM concentrations. The experimental times were 24, 
48 and 72 hours. 
Mouse pancreatic islet endothelial MS1 cells were seeded (12,500 cells/cm2) in DMEM medium 
supplemented with 1% glutamine, 1% (v/v) antibiotic solution, 10% (v/v) fetal bovine serum (FBS) 
and maintained at 37°C in a humidified atmosphere of 5% CO2 in air. Twenty-four hours after 
seeding, culture medium was removed and replaced by the same medium not supplemented or 
supplemented with Fe3O4, Fe3O4+CLA2, Fe3O4-SiO2, and Fe3O4-SiO2+CLA2 at the concentrations 
8 µg or 16 µg of NPs/100,000 cells. The experimental times were 24, 48 and 72 hours. 
 
2.7.1 Cell viability 
Cell viability was evaluated by means of the MTT assay after 24, 48 and 72 hours of treatment, 4T1 
or MS1 cells grown in multiwells were added with 30 µl of 4.5-dimethylthiazol-2-yl-,5 
diphenyltetrazolium bromide (MTT, 5 mg/ml) in PBS solution, and incubated for 3 h at 37°C in a 
humidified atmosphere of 5% CO2 in air. After the supernatants were removed and 150 µl of DMSO 
was added to each well. After 20 minutes of incubation, the absorbance was measured at 590 nm 
using a microplate reader (Dynatech MR580 microElisa, USA). 
 
2.7.2 Iron staining 
After 24 and 72 hours of treatment in chamber slides, the iron stain KIT HT20 (Sigma-Aldrich Co., 
St Louis, MO, USA) was used to evidence the SPIONs functionalized or not with CLA internalized 
by 4T1 and MS1 cells. 
 
2.7.3 CLA percentage content in incubated cells 
As indication of CLA-capped NP internalization, the CLA percentage content was determined in 
lipids extracted from 6x106 cells previously incubated with Fe3O4, Fe3O4+CLA1, Fe3O4+CLA2 or 
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Fe3O4-SiO2+CLA2 NPs for 72 hours. After treatment, the cells were washed with PBS+EDTA 
(0.53 mM), detached with trypsin/EDTA (0.25%/0.3%), and centrifuged at 600 g for 10 min at 4 
°C. 
Lipids, isolated by Folch et al. method [17], were suspended in 0.5 ml of methanol containing 
internal standard 1,2-dihenarachidoyl-sn-glycero-phosphocholine. The method of Klem et al. [18] 
for analysis of red blood cell fatty acid composition was adapted for the determination of CLA in 
4T1 cell lipids. The extracts were evaporated under nitrogen flow, dissolved with chilled methanol 
containing 2,6 di-ter-butyl-4-methyl-phenol (BHT) as antioxidant, treated for 15 min in an 
ultrasound bath and then centrifuged. The supernatants were treated with a methanol solution of 
sodium methoxide to synthetize CLA methyl esters, and after 5 min a hydrochloric acid solution 
was added. CLA methyl esters were extracted twice with hexane, evaporated under nitrogen flow at 
35° C, and re-dissolved in hexane containing BHT for injection in gas chromatograph–mass 
spectrometer. CLA were identified and quantified with a mass spectrometer operating in electron 
impact ionization (EI) mode. The selection of ions for selective ion monitoring (SIM) was based on 
comparison with standards and those reported in the literature [19, 20]. 
 
2.8 Statistical Analysis 
All data are expressed as means ± SD. Differences between group means were assessed by analysis 
of variance followed by a post hoc Newman–Keuls test. 
 
3. Results 
3.1. Nanoparticles synthesis and characterization 
The superparamagnetic properties and the XRD pattern of Fe3O4 NPs obtained with analogue 
procedure have been previously assessed [21]. Figure 1 shows STEM analyses of Fe3O4+CLA1, 
Fe3O4-NW+CLA1, Fe3O4+CLA1-TS, Fe3O4-NW+CLA1-TS, Fe3O4+CLA2 and Fe3O4-SiO2+CLA2 
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NPs. All NPs present a spherical shape with a dimensional range of about 5-15 nm, with the 
exception of silica coated NPs, seeming slightly bigger (up to 20 nm). A silica shell (of about 1-2 
nm) is well visible in the micrograph (last panel of figure 1) and is evidenced by arrows. 
 
Figure 1. STEM images of SPIONs. Fe3O4+CLA1, washed CLA-capped Fe3O4 NPs; Fe3O4-
NW+CLA1, not washed CLA-capped Fe3O4 NPs; Fe3O4+CLA1-TS, washed two step CLA-capped 
Fe3O4 NPs; Fe3O4-NW+CLA1-TS NPs, not washed two step CLA-capped Fe3O4 NPs; 
Fe3O4+CLA2; Fe3O4-SiO2+CLA2, silica shell-coated, washed CLA-capped Fe3O4 NPs. 
CLA1, 3.0 µl of CLA/ml of NPs; CLA2, 4.5 µl of CLA/ml of NPs. 
 
FT-IR spectra of pure CLA, Fe3O4+CLA1, Fe3O4-NW+CLA1, Fe3O4+CLA1-TS, Fe3O4-
NW+CLA1-TS are reported in Figure 2. Figure 2a shows the spectrum of CLA, in which two peaks 
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at about 2852 e 2922 cm-1 are assigned respectively to the asymmetric and symmetric stretching of 
CH2; the peak at about 1710 cm-1 can be attributed to the C=O stretch vibration, the peak at 1460 
cm-1  to the –COO- asymmetric stretch vibration [14], the peak at 1408 to the “umbrella” bending 
mode of CH3 group [14], the band between 1250 and 1285 cm-1 can be associated to the presence of 
the C–O stretch or more generally to the vibration of the COOH group in oleic acid [22,23], the 
peaks at 981 and 945 cm-1  are characteristic of the cis,trans conjugated dienes [24] and the peak at 
about 720 cm-1 can be assigned both to CH2 bending or rocking vibration and CH=CH vibration 
[24,23]. No significant differences can be observed in the FT-IR spectrum of pure CLA treated at 
80°C (not reported), as a confirmation that the functionalization procedure does not alter the 
molecule. Figure 2b shows the whole spectrum for all NPs, showing peaks at about 560 cm-1, 
ascribable to Fe-O stretching vibrational mode of Fe3O4, peaks at about 2852 e 2922 cm-1 that can 
be assigned respectively to the asymmetric and symmetric stretching of CH2 group of CLA, and a 
peak at about 1408 cm-1 which can be ascribed to the “umbrella” bending mode of CH3 group [14]. 
Focusing the analysis between 1000 and 4000 cm-1 (Figure 2c), it is possible to notice also the 
presence of a broad band at about 1500 - 1640 cm-1 that can be attributed to the asymmetric and 
symmetric stretch vibration of COO- group reported in literature for fatty acids adsorbed on Fe3O4 
[14,22]. Moreover, in the Fe3O4+CLA1-TS and Fe3O4-NW+CLA1-TS curves, the band at about 
1250-1285 cm-1 and the peak at about 1710 cm-1 appeared (the first one ascribed to the C-O stretch 
vibration, or to the vibration of the COOH group in oleic acid [22,23], the second one to the C=O 
stretch vibration [14]).  
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Figure 2. FT-IR spectra. (a) FT-IR spectra of pure CLA; (b) whole spectrum of Fe3O4-NW+CLA1 
(curve I), Fe3O4-NW+CLA1-TS (curve II), Fe3O4+CLA1 (curve III), Fe3O4+CLA1-TS (curve IV) 
NPs; (c) selected windows between 1000 and 4000 cm-1. 
See legend in Figure 1 for NP acronyms. 
 
The FT-IR spectra of Fe3O4+CLA2 and Fe3O4-SiO2+CLA2 NPs are reported in Figure 3. The silica 
presence is evidenced by: a new peak at about 1060 cm-1 , attributed to the asymmetric stretching of 
the Si-O-Si group, two peaks at 960 and 780 cm-1 , attributed Si-OH stretching vibration and Si–O–
Si symmetric stretching [25,26], and a band at about 3000-3300 cm-1 , ascribable to OH groups. The 
peaks at 2852 e 2922 cm-1 can be assigned respectively to the asymmetric and symmetric stretching 
of CH2 group of CLA, the band at about 1500 - 1640 cm-1, attributed to the asymmetric and 
symmetric stretch vibration of adsorbed COO- group [14,22], and the peak at about 1408 cm-1 
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ascribed to the “umbrella” bending mode of CH3 group. Also in this samples the peak at about 1710 
cm-1, ascribable to the C=O vibration of CLA, appears. 
 
Figure 3. FT-IR spectra. FT-IR spectra of Fe3O4+CLA2 (curve I) and Fe3O4-SiO2+CLA2 (curve II) 
NPs. 
See legend in Figure 1 for NP acronyms. 
 
Figure 4 reports the behavior of the various NP suspensions after different times of sedimentation. 
The precipitation of Fe3O4+CLA1 NPs starts after 5 minutes and is already complete after 30 
minutes. The Fe3O4+CLA2 and Fe3O4-SiO2+CLA2 solutions are both still stable after 2 hours, and 
only Fe3O4-SiO2+CLA2 also after 24 hours. 
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Figure 4. Precipitation of SPIONs. Time of precipitation of NPs with or without silica, capped or 
not with CLA. See table 1 for NPs acronyms.  
 
3.2 The effect of SPIONs and CLA alone on mouse breast cancer 4T1 cells and on mouse 
pancreatic islet endothelial MS1 cells. 
SPIONs, washed or not, and SPIONs functionalized with CLA (low and high amount,  one- or two-
steps) were tested to choose the preparation showing the highest inhibition of 4T1 cell proliferation. 
All functionalized particles decrease cell number in comparison with SPIONs not functionalized 
with CLA (Fe3O4), being the major inhibition obtained by SPIONs washed and capped with CLA 
with one-step procedure (data not shown). Therefore, in the following experiments, only Fe3O4, 
Fe3O4+CLA1 and Fe3O4+CLA2, with or without silica shell, were compared. 
Figure 5 shows the percentages of viability in cells treated with various SPIONS in comparison 
with the control cells, set to 100%. The viability in cells treated with Fe3O4+CLA1, Fe3O4+CLA2 or 
Fe3O4-SiO2+CLA2 is lower than in control cells and in cells treated with Fe3O4 and Fe3O4-SiO2.  
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Figure 5 Viability of mouse breast cancer 4T1 cells exposed to Fe3O4 NPs coated or not with silica 
and capped or not with CLA. The values are means ± S.D. of 4 experiments and are expressed as % 
of control cells set equal to 100 %. The absorbance values of control are 0.591 ± 0.192 for 24 hours, 
1.457 ± 0.151 for 48 hours and 1.596 ± 0.168 for 72 hours. For each NP quantity (8 or 16 µg), 
means with different letters are significantly different from one another (p<0.05) as determined by 
analysis of variance followed by a post-hoc Newman-Keuls test. 
See table 1 for NPs acronyms. C, control cells (black line); 8 µg, 16 µg, were the quantity of 
various NPs added to 100,000 cells. 
 
When the cells were treated with SPIONs coated or not with silica and capped or not with CLA, the 
reduction of viability is higher in cells treated with Fe3O4+CLA2 than in the cells treated with other 
ones. No significant difference was found between 48 and 72 hours for cells treated with 
SPIONs+CLA for both quantity of NPs. The NP internalization by cells was evidenced with iron 
staining (Figure 6). NPs functionalized or not with CLA are present in the cells, whereas no staining 
is evident in cells untreated with NPs. The analysis by gas chromatography-mass spectrometry of 
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lipids extracted from 4T1 cells incubated with SPIONs coated or not with silica and capped or not 
with CLA  shows that CLA is incorporated in lipids, and it is higher in cells treated with 
Fe3O4+CLA2 in comparison with cells treated with Fe3O4+CLA1 NPs (Table 2). With regards the 
incorporation of CLA in lipids extracted from 4T1 cells incubated with Fe3O4-SiO2+CLA2, the 
Table 2 showed a lesser incorporation of CLA for isomer 1 and 2 and a slight increase for the 
isomer 3. 
 
Figure 6. Iron staining. Prussian blue staining was used to evidence the presence of SPIONs with 
and without silica capped or not with CLA in the mouse breast cancer 4T1 cells. It was reported 
only the iron staining relative to 16 µg/100,000 cells of various SPIONS after 72 hours of treatment. 
C, control cells without SPIONs; see table 1 for NPs acronyms. 
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Table 2: Conjugated linoleic acid (CLA) in lipids extracted from 4T1 cells treated for 72 hours with 
SPIONS coated or not with silica and capped or not with CLA.. The values are means of two 
experiments and are expressed as number of times the control cells (C) set equal to 1. See legend in 
table 1 for NPs acronyms. 16 µg were the quantity of NPs added to 100,000 cells. 
Sample CLA: 3 isomers  
 Isomer n. 1 Isomer n. 2 Isomer n. 3 
C 1 1 1 
Fe3O4 16 µg 0.90 0.72 0.68 
Fe3O4+CLA1 16 µg 1.97 15.30 1.08 
Fe3O4+CLA2 16 µg 2.75 19.70 1.26 
Fe3O4-SiO2+CLA2 16 µg 1.52 1.64 1.61 
 
The effect of CLA alone on 4T1 cell viability is reported in Table 3. Two concentrations of CLA 
similar to the quantity used for the preparation of SPIONS were added to the 4T1 cells. A time-
dependent reduction of cell viability was observed. 
 
Table 3 Viability of mouse breast cancer 4T1 cells exposed to CLA 
  
Sample 24 h 48 h 72 h 
C 100 100 100 
CLA 10 µM 91.7 69.1 72.0 
CLA 25 µM 86.5 69.2 69.5 
The values are means of 2 experiments and are expressed as % of control cells set equal to 100 %. 
The absorbance values of control are 0.591 ± 0.192 for 24 hours, 1.457 ± 0.151 for 48 hours and 
1.596 ± 0.168 for 72 hours. 
C, control cells. 
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To verify whether the different types of SPIONS affected in different way normal and cancer cells, 
pancreatic islet endothelial MS1 cells were treated. For these experiments, only CLA2 (4.5 µl CLA/ 
ml of NPs) was used. Table 4 shows that no decrease of viability was induced by all types of 
SPIONS in comparison with control cells. In particular there were no differences between SPIONS 
capped or not with CLA.  
 
Table 4 Viability of pancreatic islet endothelial MS1 cells exposed to Fe3O4 NPs coated or not with 
silica and capped or not with CLA. The values are means of 2 experiments and are expressed as % 
of control cells set equal to 100 %. The absorbance values of control are 0.256 for 24 hours, 0.771 
for 48 hours and 0.601 for 72 hours. 
See table 1 for NPs acronyms. C, control cells; 8 µg, 16 µg, were the quantity of various NPs added 
to 100,000 cells. 
  
Sample 24 h 48 h 72 h 
 8 µg 16 µg 8 µg 16 µg 8 µg 16 µg 
C 100 100 100 100 100 100 
Fe3O4  97.09 103.41 111.47 103.24 151.99 140.76 
Fe3O4+CLA2  94.80 104.86 125.76 103.63 146.53 133.11 
Fe3O4-SiO2  101.56 110.86 114.02 107.13 127.03 131.44 
Fe3O4-SiO2+CLA2  102.94 114.79 118.96 94.16 136.76 148.91 
 
Figure 7 reports that NPs coated or not with silica and capped or not with CLA are present in the 
MS1 cells. 
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Figure 7. Iron staining for MS1 cells. 
Prussian blue staining was used to evidence the presence of SPIONs with and without silica capped 
or not with CLA in pancreatic islet endothelial MS1 cells. 
It was reported only the iron staining relative to 16 µg/100,000 cells of various SPIONS after 24 
hours of treatment. See table 1 for NP acronyms. 
 
4. Discussion 
In recent years, NPs have been proposed for biomedical utilization [27-31]. This approach implies 
the synthesis of biocompatible NPs, which are also stable and easily manageable in biological 
media. For this reason, several coatings have been proposed to improve colloidal stability, prevent 
oxidation, and improve biocompatibility of NPs [10]. Among them, fatty acids have been also 
investigated. 
Some authors have used OA, which belongs to unsaturated monocarboxylic acids, to functionalize 
Fe3O4 NPs; in particular the study reported by Hemei Chen et al. [32] showed that OA capped 
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Fe3O4 NPs possessed high magnetization and were useful to further adsorb other 
biomacromolecules. Other studies, instead of using a single adsorption layer of OA, stabilized 
magnetic NPs by short-chain-length monocarboxylic acids, such as lauric acid and myristic acid 
[33], but the magnetic NPs were in part aggregated [34]. However, magnetic NPs coated with 
myristic or lauric acids were cytotoxic for glioblastoma cells, showing low toxicity for normal 
astrocytes [33]. Starting from the evidence that fatty acids seem biocompatible for healthy cells and 
toxic for cancer cells, the rationale of their use as capping agent for magnetic NPs should be 
adjusted, trying to optimize their role as NPs driven therapeutic agents, not only as biocompatible 
surfactants. 
In this study, CLA was chosen as capping agent for magnetic NPs for its antitumor properties [11-
13]; its effect on colloidal stability of NPs suspensions and its potential therapeutic effect, when 
grafted on NPs, were evaluated. The effect of silica coating was also investigated. The 
superparamagnetic properties of pure Fe3O4 NPs were previously assessed [21]. The size and 
morphology of the NP batch prepared for this research were investigated and a good reproducibility 
of the results was observed in respect of previous preparations, both for uncoated and silica coated 
magnetic NPs. The presence of CLA on the magnetic NPs was evidenced by the FT-IR analysis. 
The results showed the presence of iron oxide and of organic species ascribable to CLA on all 
samples. It can therefore be assumed that  all the functionalization methods were successful. 
Interestingly it can be evidenced that different signals ascribable to CLA, which could be related to 
the presence of a single- or bi-layered configuration, were present. All functionalized particles 
showed the signals related to the CLA main chain (2852 e 2922 cm-1 of CH2 group and 1408 cm-1 
of CH3 group [14]). Moreover, in all functionalized NPs also the band ascribed to asymmetric and 
symmetric stretch vibration of COO- group (1500-1640 cm-1) appeared [14,22]. This band was not 
present in the FT-IR spectrum of pure CLA (i.e. not adsorbed on any support) since it can be related 
to the covalent interaction between COO- groups and Fe atoms in a chelating bidentate interaction 
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with iron oxide surfaces [22]. The patterns of the Fe3O4+CLA1-TS and Fe3O4-NW+CLA1-TS 
revealed signals also present in not adsorbed CLA (1250-1285 cm-1 for C-O [22,23] and 1710 cm-1 
C=O [14]), but absent in the patterns of CLA adsorbed on NPs with a single-step procedure and low 
CLA content (see for example the patterns of Fe3O4+CLA1, Fe3O4-NW+CLA1 and [23]), as a 
demonstration of the presence of free –COOH groups exposed on the NP surface, typical of a bi-
layer configuration [14]. The functionalization with highest CLA amount, even in a single step 
(Fe3O4+CLA2 and Fe3O4- SiO2+CLA2), gave FT-IR results similar to Fe3O4+CLA1-TS and Fe3O4-
NW+CLA1-TS NPs both with and without the presence of silica shell. In this case the excess of 
CLA probably produced a secondary layer, with a configuration similar to the one obtained by the 
two-step synthesis procedure [14]. 
The NPs functionalized with CLA in a one step were chosen, among different preparations of 
SPIONs, because they reduced cell viability more than NPs coated with CLA with two-step 
procedure (data not shown). Two amounts of CLA (one step) were used: Fe3O4+CLA1 (3 µl 
CLA/ml of NPs) and Fe3O4+CLA2 (4.5 µl of CLA/ml of NPs). The results obtained showed that 
both Fe3O4+CLA1 and Fe3O4+CLA2 reduced the cell viability of 4T1 cells treated for 24 and 72 
hours, respect to control cells not incubated with SPIONs and to 4T1 cells incubated with SPIONs 
without CLA, but Fe3O4+CLA2 was more effective in the reduction than Fe3O4+CLA1. For 
Fe3O4+CLA2, the viability values were not significantly different between 48 and 72 hours. A 
similar trend was observed in 4T1 cells treated with CLA alone. 
To be noted that the experiments, carried out to evaluate the effect of various SPIONS on normal 
cells, showed that SPIONS capped or not with CLA2 and coated or not with silica did not decrease 
the viability of the normal MS1 cells.  
The NP precipitation time with both CLA amounts was also determined. Although all the particles 
seem aggregated in STEM images of Figure 1 suspensions stable up to 24h were obtained (Figure 
4), as discussed in the following. This observation may be explained by the fact that STEM images 
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of the particles were obtained after drying a drop (5 µl) of the suspension onto a carbon coated 
copper TEM grid. Upon drying onto a substrate particles obviously aggregates and appear as 
agglomerates in the images.  
As shown in Figure 4 the precipitation time was shorter for Fe3O4+CLA1 than for Fe3O4+CLA2: at 
30 min Fe3O4+CLA1 NPs were all precipitated, while Fe3O4+CLA2 NPs remained in suspension up 
to 2 hours. This difference can be explained taking into account that Fe3O4+CLA2, even if 
synthesized with one step procedure, were covered by a secondary layer of CLA (see FT-IR 
results). It can be supposed that the highest amount of CLA caused a condition similar to that of 
bilayer-coated NPs (even if the bilayer was probably not continuous). It is reasonable that 
Fe3O4+CLA2 NP surface is more hydrophilic in comparison to that of Fe3O4+CLA1 ones (which do 
not expose free -COOH groups) and, in turn, NPs show a better stability in aqueous medium. 
The determination, by gas chromatography-mass spectrophotometry, of CLA isomers in the lipids 
extracted from cells incubated with SPIONs functionalized or not with CLA, showed that this fatty 
acid was more incorporated in the cells treated with Fe3O4+CLA2 NPs than in the cells treated with 
Fe3O4+CLA1 NPs. The results of this study indicate that the use of the highest amount of CLA (4.5 
µl/1 ml of NPs) improves the suspension stability, the CLA incorporation into the cells and the 
antitumor activity. It worth of mentioning that it is very important to avoid the formation of 
clusters, because they partially lose the magnetic properties, and, when injected intravascularly, 
show a shorter circulation time due to rapid clearance by monocytes, this decreasing the reaching of 
target cells or tissues. 
Interestingly the NPs coated with a thin layer of silica and functionalized with CLA showed a 
further increase of time required to have the precipitation, in fact at 24 hours Fe3O4-SiO2+CLA2 
NPs were all dispersed in solution. This effect can be mainly attributed to the citric acid 
functionalization needed for silica coating, and cannot be ascribed exclusively to CLA amount. 
Fe3O4-SiO2+CLA2 NPs also cause a reduction of cell viability in comparison with control cells and 
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CLA-free Fe3O4-SiO2, but the inhibition was lower than that obtained with Fe3O4+CLA2. In the 
same way, the incorporation of CLA in lipid extracted from the cells treated with Fe3O4-
SiO2+CLA2 NPs was lower for the isomers 1 and 2 than that obtained with Fe3O4+CLA2. 
This difference could be ascribed to the role of the silica shell avoiding the direct contact between 
the magnetite NPs and the biological environment, which in turn reduces their potential toxicity. 
Moreover, according to the reported data, we can infer that fatty acids may improve the affinity 
between NPs and cell membrane and favor particle internalization in tumor cells. This is an 
important issue for future research, for example for studies with other cancer cell lines as well as for 
magnetic NP-assisted gene therapy, to improve the use of viral vectors to transfer therapeutic genes 
to target cells [35-37]. 
 
5. Conclusions 
In this research colloidal suspensions of Fe3O4 NPs, both uncoated or coated by silica shell, of 
about 5-20 nm in diameter, were successfully prepared and functionalized with different amounts of 
CLA both in single- and bi-layer configurations. Both the silica shell and CLA layer played a role in 
determining suspension stability, especially when CLA was grafted on the NP surface in a bi-layer 
configuration. The results evidenced that the viability of mouse breast cancer 4T1 cells was reduced 
in presence of Fe3O4 NPs functionalized with CLA in comparison with both untreated control cells 
and cells treated with CLA-free NPs. The presence of the silica coating in CLA capped NPs caused 
a lesser inhibition of cell viability. Since it is known that the colloidal stability must be assured to 
avoid uncontrolled NPs clusterization, loosening of magnetic properties and short circulation time, 
control of this parameter is crucial, even if it is not directly related to the antitumoral effect 
observed in this work. Based on these results, silica shell free Fe3O4 NPs functionalized with high 
amount of CLA (with bi-layered configuration) can be suggested as therapeutic carriers for their 
good dispersion and ability to decrease mouse breast cancer 4T1 cell viability. 
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Figure Captions 
Figure 1. STEM images of SPIONs. 
Fe3O4+CLA1, washed CLA-capped Fe3O4 NPs; Fe3O4-NW+CLA1, not washed CLA-capped Fe3O4 
NPs; Fe3O4+CLA1-TS, washed two step CLA-capped Fe3O4 NPs; Fe3O4-NW+CLA1-TS NPs, not 
washed two step CLA-capped Fe3O4 NPs; Fe3O4+CLA2; Fe3O4-SiO2+CLA2, silica shell-coated, 
washed CLA-capped Fe3O4 NPs. 
CLA1, 3.0 µl of CLA/ml of NPs; CLA2, 4.5 µl of CLA/ml of NPs. 
 
Figure 2. FT-IR spectra. 
(a) FT-IR spectra of pure CLA; (b) whole spectrum of Fe3O4-NW+CLA1 (curve I), Fe3O4-
NW+CLA1-TS (curve II), Fe3O4+CLA1 (curve III), Fe3O4+CLA1-TS (curve IV) NPs; (c) selected 
windows between 1000 and 4000 cm-1. 
See table 1 for NPs acronyms. 
 
Figure 3. FT-IR spectra. 
FT-IR spectra of Fe3O4+CLA2 (curve I) and Fe3O4-SiO2+CLA2 (curve II) NPs. 
See table 1 for NPs acronyms. 
 
Figure 4. Precipitation of SPIONs 
Time of precipitation of NPs with or without silica, capped or not with CLA 
See table 1 for NPs acronyms.  
 
Figure 5 Viability of mouse breast cancer 4T1 cells exposed to Fe3O4 NPs coated or not with silica 
and capped or not with CLA. 
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The values are means ± S.D. of 4 experiments and are expressed as % of control cells set equal to 
100 %. The absorbance values of control are 0.591 ± 0.192 for 24 hours, 1.457 ± 0.151 for 48 hours 
and 1.596 ± 0.168 for 72 hours. 
For each NP quantity (8 or 16 µg), means with different letters are significantly different from one 
another (p<0.05) as determined by analysis of variance followed by a post-hoc Newman-Keuls test. 
See table 1 for NPs acronyms. 
C, control cells (black line); 8 µg, 16 µg, were the quantity of various NPs added to 100,000 cells. 
 
Figure 6. Iron staining. 
Prussian blue staining was used to evidence the presence of SPIONs with and without silica capped 
or not with CLA in the mouse breast cancer 4T1 cells. 
It was reported only the iron staining relative to 16 µg/100,000 cells of various SPIONS after 72 
hours of treatment. 
C, control cells without SPIONs; see table 1 for NP acronyms. 
 
Figure 7. Iron staining for MS1 cells. 
Prussian blue staining was used to evidence the presence of SPIONs with and without silica capped 
or not with CLA in pancreatic islet endothelial MS1 cells. 
It was reported only the iron staining relative to 16 µg/100,000 cells of various SPIONS after 24 
hours of treatment. 
See table 1 for NP acronyms. 
 
 
